ZA200810528B - Procedure and methods for detecting Alzheimer's disease - Google Patents
Procedure and methods for detecting Alzheimer's diseaseInfo
- Publication number
- ZA200810528B ZA200810528B ZA200810528A ZA200810528A ZA200810528B ZA 200810528 B ZA200810528 B ZA 200810528B ZA 200810528 A ZA200810528 A ZA 200810528A ZA 200810528 A ZA200810528 A ZA 200810528A ZA 200810528 B ZA200810528 B ZA 200810528B
- Authority
- ZA
- South Africa
- Prior art keywords
- disease
- procedure
- methods
- detecting alzheimer
- alzheimer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0604294A FR2900936B1 (fr) | 2006-05-15 | 2006-05-15 | Procede et methodes de detection de la maladie d'alzheimer |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200810528B true ZA200810528B (en) | 2009-10-28 |
Family
ID=37496633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200810528A ZA200810528B (en) | 2006-05-15 | 2008-12-11 | Procedure and methods for detecting Alzheimer's disease |
Country Status (12)
Country | Link |
---|---|
US (1) | US20100055682A1 (zh) |
EP (1) | EP2021509A2 (zh) |
JP (1) | JP2009537133A (zh) |
KR (1) | KR20090098941A (zh) |
CN (1) | CN101490280B (zh) |
AU (1) | AU2007251408B2 (zh) |
CA (1) | CA2652258A1 (zh) |
FR (2) | FR2900936B1 (zh) |
IL (1) | IL195288A (zh) |
NZ (1) | NZ573505A (zh) |
WO (1) | WO2007132120A2 (zh) |
ZA (1) | ZA200810528B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2929292A1 (fr) | 2008-03-28 | 2009-10-02 | Exonhit Therapeutics S A Sa | Procede et methodes de diagnostic de la maladie d'alzheimer |
US9476872B2 (en) | 2008-05-23 | 2016-10-25 | Mochida Pharmaceutical Co., Ltd | Method for evaluation of function of phagocyte |
US20100099609A1 (en) * | 2008-07-28 | 2010-04-22 | Buck Institute For Age Research | eAPP AND DERIVATIVES FOR TREATMENT OF ALZHEIMER'S DISEASE |
KR101295019B1 (ko) * | 2011-04-22 | 2013-08-09 | 경북대학교 산학협력단 | 리포칼린 2 수준을 측정하는 것을 포함하는 경도 인지 장애 진단용 조성물, 키트 및 경도인지 장애 진단을 위한 정보 제공방법. |
US9541561B2 (en) | 2012-06-14 | 2017-01-10 | Electronics And Telecommunications Research Institute | Method for diagnosing Alzheimer's disease using biomaterial |
EP2728015A1 (en) * | 2012-10-31 | 2014-05-07 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for the Sezary's Syndrome diagnosis |
CA2975670A1 (en) * | 2014-08-13 | 2016-02-18 | James Archibald TIMMONS | Healthcare diagnostic |
CN104328200B (zh) * | 2014-11-18 | 2016-04-06 | 宁波大学 | 辅助诊断阿尔茨海默病的检测试剂盒及其检测方法 |
WO2019049705A1 (ja) * | 2017-09-08 | 2019-03-14 | 自然免疫制御技術研究組合 | アルツハイマー症診断装置及び方法 |
CN118234518A (zh) * | 2021-07-27 | 2024-06-21 | 香港科技大学 | 用于治疗阿尔茨海默病的组合物和方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0791660A1 (en) * | 1996-02-22 | 1997-08-27 | Smithkline Beecham Corporation | A novel diagnostic marker for splicing variants of genes associated with neurological function |
CA2417134A1 (en) * | 2000-07-25 | 2002-01-31 | The Sir Mortimer B. Davis - Jewish General Hospital | Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
WO2003063907A1 (fr) * | 2002-01-31 | 2003-08-07 | Celestar Lexico-Sciences, Inc. | Medicaments ameliorant les troubles du rythme circadien |
WO2003086462A1 (fr) * | 2002-03-29 | 2003-10-23 | Celestar Lexico-Sciences,Inc. | Inhibiteurs de phosphorylation c-jun |
US7250496B2 (en) * | 2002-11-14 | 2007-07-31 | Rosetta Genomics Ltd. | Bioinformatically detectable group of novel regulatory genes and uses thereof |
GB0227238D0 (en) * | 2002-11-21 | 2002-12-31 | Diagenic As | Product and method |
-
2006
- 2006-05-15 FR FR0604294A patent/FR2900936B1/fr not_active Expired - Fee Related
-
2007
- 2007-05-14 JP JP2009510510A patent/JP2009537133A/ja active Pending
- 2007-05-14 AU AU2007251408A patent/AU2007251408B2/en not_active Ceased
- 2007-05-14 US US12/227,374 patent/US20100055682A1/en not_active Abandoned
- 2007-05-14 CN CN2007800267862A patent/CN101490280B/zh not_active Expired - Fee Related
- 2007-05-14 NZ NZ573505A patent/NZ573505A/en not_active IP Right Cessation
- 2007-05-14 EP EP07766039A patent/EP2021509A2/fr not_active Withdrawn
- 2007-05-14 KR KR1020087030380A patent/KR20090098941A/ko not_active Application Discontinuation
- 2007-05-14 CA CA002652258A patent/CA2652258A1/fr not_active Abandoned
- 2007-05-14 WO PCT/FR2007/051263 patent/WO2007132120A2/fr active Application Filing
-
2008
- 2008-11-13 IL IL195288A patent/IL195288A/en not_active IP Right Cessation
- 2008-12-11 ZA ZA200810528A patent/ZA200810528B/xx unknown
-
2012
- 2012-11-21 FR FR1261064A patent/FR2980484A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP2021509A2 (fr) | 2009-02-11 |
IL195288A0 (en) | 2009-08-03 |
FR2900936B1 (fr) | 2013-01-04 |
WO2007132120A3 (fr) | 2008-05-08 |
KR20090098941A (ko) | 2009-09-18 |
AU2007251408B2 (en) | 2012-11-29 |
FR2980484A1 (fr) | 2013-03-29 |
CA2652258A1 (fr) | 2007-11-22 |
IL195288A (en) | 2013-10-31 |
CN101490280B (zh) | 2012-09-26 |
NZ573505A (en) | 2011-04-29 |
FR2900936A1 (fr) | 2007-11-16 |
AU2007251408A1 (en) | 2007-11-22 |
JP2009537133A (ja) | 2009-10-29 |
WO2007132120A2 (fr) | 2007-11-22 |
CN101490280A (zh) | 2009-07-22 |
US20100055682A1 (en) | 2010-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200810528B (en) | Procedure and methods for detecting Alzheimer's disease | |
IL211540A0 (en) | Optical method for the detection of alzheimer's disease | |
PL2324126T3 (pl) | Sposób identyfikacji czynników ryzyka choroby Alzheimera | |
IL188165A0 (en) | Method for the diagnosis of alzheimer's disease | |
BRPI0715287A2 (pt) | "método de avaliação do progresso de cicatrização de feridas" | |
EP1986927A4 (en) | IMPROVED LABELING PROCESSOR AND RELATED METHOD | |
EP2091566A4 (en) | COMBINATION THERAPIES AGAINST ALZHEIMER DISEASE AND SIMILAR ILLNESSES | |
DE602006009764D1 (de) | Terphenylderivate zur Alzheimerbehandlung | |
EP2011513A4 (en) | THERAPEUTIC AGENTS AGAINST ALZHEIMER DISEASE AND CANCER | |
EP2018163A4 (en) | ILLUSTRATIVE APPARATUS AND METHOD | |
EP2198292A4 (en) | BETTER DIAGNOSIS OF ALZHEIMER'S DISEASE | |
EP2046396A4 (en) | METHOD AND MEANS FOR PRODUCING 18F RAY-MARKED FLUORINATING AGENTS | |
EP1877416A4 (en) | SAPOSIN D AND FAM3C ARE BIOLOGICAL MARKERS FOR ALZHEIMER DISEASE | |
EP2231180A4 (en) | VACCINE AGAINST ALZHEIMER'S DISEASE | |
GB0616919D0 (en) | Cyclist's Aid | |
EP2375895A4 (en) | METHOD OF TREATING ALZHEIMER'S DISEASE AND RELATED STATES | |
EP2344881A4 (en) | BIOMARKER FOR MORBUS ALZHEIMER | |
GB0620695D0 (en) | Composition and methods for the treatment of nurdegenerative disease | |
EP1909836A4 (en) | METHODS OF TREATING AND DETECTING BETA CELL ASSOCIATED DISEASE | |
EP2147117A4 (en) | METHOD FOR DIAGNOSIS OF MORBUS ALZHEIMER AND MARKERS IDENTIFIED BY SET ASSOCIATION | |
EP2305629A4 (en) | THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE | |
EP1832877A4 (en) | METHOD FOR THE STUDY OF MORBUS ALZHEIMER | |
EP2099476A4 (en) | METHODS OF TREATING ALZHEIMER'S DISEASE | |
EP1863510A4 (en) | METHOD FOR TREATING PARKINSON DISEASE | |
HU0600409D0 (en) | Izatin and it's derivatives for use as a medicine |